New research highlights combined impact of genes and lifestyle on dilated cardiomyopathy
An international team, led by scientists from the Victor Chang Cardiac Research Institute has studied around 3000 people…
Study links epigenetic markers to cardiovascular risk in type 2 diabetes
People with type 2 diabetes are up to four times more likely to have heart attacks, strokes, anginas…
Alzheimer’s research reaches a critical tipping point
One-third of people older than 85 in the United States are estimated to live with Alzheimer’s disease today,…
‘Storm’ of Noncommunicable Diseases May Hit South America
A new report from the Pan American Health Organization (PAHO), titled Major storm on the horizon, warns that…
Vital role of physical activity in early type 2 diabetes care
New research to be presented at this year’s Annual Meeting of the European Association for the Study of…
Genetic testing can guide safer chemotherapy for gastrointestinal cancer patients
For some patients with gastrointestinal (GI) cancers like colorectal and pancreatic cancer, chemotherapy can cause severe, sometimes life-threatening…
Scientists link brain lithium loss to early Alzheimer’s changes
A new study reveals that brain lithium depletion occurs early in Alzheimer’s and fuels disease progression, while low-dose…
Scientists map the genes behind diet and dementia risk
Scientists reveal a new genetic resource from the MIND diet trial, opening the door to precision nutrition strategies…
Many patients with high-risk myelodysplastic syndromes do not receive guideline-recommended treatment
Most patients with high-risk myelodysplastic syndromes (MDS) do not receive guideline-recommended treatment with hypomethylating agents (HMAs), according to…
Alzheimer’s risk factors look different for men and women
A study of over 6000 patients shows how Alzheimer’s risk is shaped by sex and age of onset,…
Are all healthy diets equal or does food processing make a difference?
A major UK trial shows that eating minimally processed foods delivers superior weight loss and appetite control, even…
Early immunotherapy shows promise for treating anti-IgLON5 disease
Researchers ask physicians to consider anti-IgLON5 disease if certain symptoms are present, as the only promising approach is…